RBC Capital Sticks to Its Buy Rating for Agios Pharma (AGIO)
In a report released on April 3, Gregory Renza from RBC Capital maintained a Buy rating on Agios Pharma (AGIO – Research Report), with a price ...
RBC Capital Sticks to Its Buy Rating for Ultragenyx Pharmaceutical (RARE)
RBC Capital analyst Luca Issi maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) on April 3 and set a price target ...
Takeaways from AP's story on safety concerns about Shell's fleet of oil production ships
An internal review of Shell's oil production ship fleet in 2022 shows that, 11 years after the Bonga spill, problems remained ...
Spanish pharma company Grifols' shares up on Brookfield talk
Shares in Spanish pharmaceutical company Grifols rose on Wednesday after Canadian fund Brookfield said it was talking with ...
American Association of Individual Investors4d
Which Is a Better Investment, Corcept Therapeutics Incorporated or Royalty Pharma plc Stock?
Learn more about whether Corcept Therapeutics Incorporated or Royalty Pharma plc is a better investment based on AAII's A+ ...